PT Industri Jamu dan Farmasi Sido Muncul (SIDO) Fundamentals 2026 — P/E 9.7x, Revenue Analysis | SniperIQ
PT Industri Jamu dan Farmasi Sido Muncul (SIDO) is a ID-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of Rp11.07T, trading at Rp376.00 on the JKT. This SniperIQ fundamentals page covers PT Industri Jamu dan Farmasi Sido Muncul's valuation (P/E 9.7x, P/B 3.4x), profitability (net margin 29.1%), revenue (Rp4.08T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Industri Jamu dan Farmasi Sido Muncul's market cap?
PT Industri Jamu dan Farmasi Sido Muncul (SIDO) has a market capitalization of approximately Rp11.07T, trading at Rp376.00 on the JKT. Market cap moves with the live share price.
What is PT Industri Jamu dan Farmasi Sido Muncul's P/E ratio?
PT Industri Jamu dan Farmasi Sido Muncul's trailing twelve-month P/E ratio is 9.7x, with a price-to-book (P/B) of 3.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Industri Jamu dan Farmasi Sido Muncul?
PT Industri Jamu dan Farmasi Sido Muncul runs a net profit margin of 29.1%, a gross margin of 57.3%, and an operating margin of 36.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Industri Jamu dan Farmasi Sido Muncul generate?
PT Industri Jamu dan Farmasi Sido Muncul reported revenue of Rp4.08T for fiscal year 2025, with net income of Rp1.23T and earnings per share (EPS) of 41.36. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Industri Jamu dan Farmasi Sido Muncul pay a dividend?
PT Industri Jamu dan Farmasi Sido Muncul offers a trailing dividend yield of about 9.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PT Industri Jamu dan Farmasi Sido Muncul financially healthy?
PT Industri Jamu dan Farmasi Sido Muncul carries a debt-to-equity ratio of 0.00x and a current ratio of 5.87x, with a market beta of -0.05. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Industri Jamu dan Farmasi Sido Muncul a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Industri Jamu dan Farmasi Sido Muncul (SIDO) the key facts are: market cap Rp11.07T, P/E 9.7x, revenue Rp4.08T, 52-week range 350-585. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Industri Jamu dan Farmasi Sido Muncul's full fundamentals live
Get PT Industri Jamu dan Farmasi Sido Muncul's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.